KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA

• Fang Cheng,

  Affiliation Genome-Scale Biology Program, Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland

  ⨯
• Magdalena Weidner-Glunde ,

  Contributed equally to this work with: Magdalena Weidner-Glunde, Markku Varjosalo

  Affiliation Institute of Virology, Hannover Medical School, Hannover, Germany

  ⨯
• Markku Varjosalo ,

  Contributed equally to this work with: Magdalena Weidner-Glunde, Markku Varjosalo

  Affiliations Genome-Scale Biology Program, Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland, Department of Molecular Medicine, National Public Health Institute (KTL), Helsinki, Finland

  ⨯
• Eeva-Marja Rainio,

  Affiliations Turku Centre for Biotechnology, BioCity, Turku, Finland, Department of Biology, University of Turku, Turku, Finland

  ⨯
• Anne Lehtonen,

  Affiliation Genome-Scale Biology Program, Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland

  ⨯
• Thomas F. Schulz,

  Affiliation Institute of Virology, Hannover Medical School, Hannover, Germany

  ⨯
• Päivi J. Koskinen,

  Affiliations Turku Centre for Biotechnology, BioCity, Turku, Finland, Department of Biology, University of Turku, Turku, Finland

  ⨯
• Jussi Taipale,

  Affiliations Genome-Scale Biology Program, Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland, Department of Molecular Medicine, National Public Health Institute (KTL), Helsinki, Finland

  ⨯
• Päivi M. Ojala

  * E-mail: paivi.ojala@helsinki.fi

  Affiliations Genome-Scale Biology Program, Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland, The Foundation for the Finnish Cancer Institute, Finland

  ⨯